Literature DB >> 26338893

SPECT Myocardial Perfusion Reserve in Patients with Multivessel Coronary Disease: Correlation with Angiographic Findings and Invasive Fractional Flow Reserve Measurements.

Fayçal Ben Bouallègue1, François Roubille2, Benoit Lattuca3, Thien Tri Cung3, Jean-Christophe Macia3, Richard Gervasoni3, Florence Leclercq3, Denis Mariano-Goulart4.   

Abstract

UNLABELLED: Quantification of myocardial perfusion reserve (MPR) is an emerging topic in nuclear cardiology with an expected diagnostic and prognostic incremental value, especially for patients with severe coronary artery disease. The advent of new dedicated solid-state cameras has opened new perspectives for perfusion quantitation in SPECT. We appraised the feasibility of perfusion reserve estimation using a cadmium zinc telluride camera in a cohort of multivessel patients and its pertinence with respect to angiographic data.
METHODS: Twenty-three patients with known multivessel coronary artery disease were prospectively enrolled. Dynamic SPECT acquisitions using (99m)Tc-tetrofosmin at rest and after vasodilator stress were performed using a dedicated cadmium zinc telluride camera. Reconstructed frames were automatically segmented to extract the vascular input function and the myocardial uptake curve. One-compartment kinetic modeling was used to estimate global and regional uptake values, and then myocardial blood flow was derived using the Renkin-Crone equation. Global and regional MPR was assessed using flow difference (stress - rest) and flow ratio (stress/rest). All patients underwent control coronary angiography within 4 wk, which served as the reference for MPR index assessment. Relevant angiographic findings included maximal stenosis and (for a subgroup of 26 vessels) invasive measurement of fractional flow reserve (FFR). A stenosis was considered obstructive if greater than 50% and an FFR abnormal if lower than 0.8.
RESULTS: Global MPR correlated well with number of obstructed vessels (P < 0.001). After multivariate analysis, both regional flow ratio and flow difference were significantly associated with maximal stenosis (P < 0.001) and FFR (P < 0.001). Regional MPR indices were significantly different in obstructed and nonobstructed vessels (P < 0.001) and in vessels with normal and abnormal FFR (P < 0.001). With a cutoff of 2, the sensitivity, specificity, and accuracy of regional flow ratio were, respectively, 80%, 85%, and 81% for the detection of obstructed vessels and 89%, 82%, and 85% for the detection of abnormal FFR.
CONCLUSION: Scintigraphic estimations of global and regional MPR in multivessel patients using a cadmium zinc telluride camera appear to correlate well with invasive angiographic findings, including maximal stenosis and FFR measurements.
© 2015 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Entities:  

Keywords:  CZT camera; dynamic SPECT; fractional flow reserve; multivessel coronary artery disease; myocardial perfusion reserve

Mesh:

Substances:

Year:  2015        PMID: 26338893     DOI: 10.2967/jnumed.114.143164

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  32 in total

1.  Feasibility of dynamic stress 201Tl/rest 99mTc-tetrofosmin single photon emission computed tomography for quantification of myocardial perfusion reserve in patients with stable coronary artery disease.

Authors:  Sangwon Han; Young-Hak Kim; Jung-Min Ahn; Soo-Jin Kang; Jungsu S Oh; Eonwoo Shin; Changhwan Sung; Sun Young Chae; Seung-Jung Park; Gillan Grimberg; Gil Kovalski; Dae Hyuk Moon
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-06-02       Impact factor: 9.236

2.  The potential of regional myocardial blood flow measurement with SPECT.

Authors:  Matthieu Pelletier-Galarneau; Terrence D Ruddy
Journal:  J Nucl Cardiol       Date:  2019-04-30       Impact factor: 5.952

3.  Advances in imaging instrumentation for nuclear cardiology.

Authors:  Jae Sung Lee; Gil Kovalski; Tali Sharir; Dong Soo Lee
Journal:  J Nucl Cardiol       Date:  2017-07-17       Impact factor: 5.952

4.  Advances in dual respiratory and ECG-gated SPECT imaging.

Authors:  Kenneth J Nichols; Andrew Van Tosh
Journal:  J Nucl Cardiol       Date:  2017-04-21       Impact factor: 5.952

5.  Gated SPECT myocardial perfusion imaging quality assurance in current and future practice.

Authors:  Kenneth J Nichols; Andrew Van Tosh
Journal:  J Nucl Cardiol       Date:  2016-12-21       Impact factor: 5.952

6.  Absolute myocardial blood flow vs relative myocardial perfusion: Which one is better?

Authors:  Tali Sharir; Gil Kovalski
Journal:  J Nucl Cardiol       Date:  2017-05-05       Impact factor: 5.952

Review 7.  Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging Guidelines: Instrumentation, Acquisition, Processing, and Interpretation.

Authors:  Sharmila Dorbala; Karthik Ananthasubramaniam; Ian S Armstrong; Panithaya Chareonthaitawee; E Gordon DePuey; Andrew J Einstein; Robert J Gropler; Thomas A Holly; John J Mahmarian; Mi-Ae Park; Donna M Polk; Raymond Russell; Piotr J Slomka; Randall C Thompson; R Glenn Wells
Journal:  J Nucl Cardiol       Date:  2018-10       Impact factor: 5.952

8.  Contemporary Cardiac SPECT Imaging-Innovations and Best Practices: An Information Statement from the American Society of Nuclear Cardiology.

Authors:  Brian G Abbott; James A Case; Sharmila Dorbala; Andrew J Einstein; James R Galt; Robert Pagnanelli; Renée P Bullock-Palmer; Prem Soman; R Glenn Wells
Journal:  J Nucl Cardiol       Date:  2018-10       Impact factor: 5.952

9.  Combined assessment of myocardial perfusion and left ventricular function by nuclear cardiology: The value of high-efficiency SPECT.

Authors:  Tali Sharir; Boris Brodkin; Gil Kovalski
Journal:  J Nucl Cardiol       Date:  2016-06-16       Impact factor: 5.952

10.  Avoiding full corrections in dynamic SPECT images impacts the performance of SPECT myocardial blood flow quantitation.

Authors:  Lei Wang; Dayong Wu; Yong Yang; Ing-Jou Chen; Chih-Yuan Lin; Bailing Hsu; Wei Fang; Yi-Da Tang
Journal:  J Nucl Cardiol       Date:  2016-06-23       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.